Objective. Histone deacytylase inhibitors (HDACis) inhibit the deacetylation of the lysine residue of proteins, including histones, and regulate the transcription of a variety of genes. Recently, HDACis have been used clinically as anti-cancer drugs and possible anti-diabetic drugs. Even though HDACis have been proven to protect the cytokine-induced damage of pancreatic beta cells, evidence also shows that high doses of HDACis are cytotoxic. In the present study, we, therefore, investigated the eff ect of HDACis on insulin secretion in a pancreatic beta cell line.
Histone deacetylase inhibitors (HDACis) are small epigenetically active molecules (Marks 2010) . Th ey induce acetylation of the lysine residues of histones, as well as non-histone proteins, following altered genes' expression in response to physiological changes in cells (Halsall et al. 2012) .
Recently, HDACis have been used clinically as anticancer drugs (Manal et al. 2016; Newbold 2016) . It has been reported that HDACis revert cytokine-induced beta cell toxicity (Larsen et al. 2007; Susick et al. 2008; Lundh et al. 2012) , improve insulin resistance (Christensen et al. 2011; Lundh et al. 2015) , enhance insulin secretion (Tiernan et al. 2015) , and stimulate pancreatic beta cell proliferation (Khan and Jena 2014; Plaisance et al. 2014) . Th erefore, HDACis are considered to be possible anti-diabetic drugs (Christensen et al. 2011; Khan and Jena 2015; Sharma and Taliyan 2016) .
In contrast, recent reports have revealed that hydroxamic acid, a group of HDACis, inhibited gene expression of beta cell markers, including Pdx1, a key transcription factor (Kubicek et al. 2012) . Th erefore, the contribution of HDACis to the amelioration of pancreatic beta cell function must be elucidated. We investigated the eff ect of the hydroxamic acid, TSA, as well as other class of HDACis, including short-chain fatty acids, valproic acid (VPA), and sodium butyrate (NaB) on pancreatic beta cell line, MIN6 cells.
Materials and Methods
Culture of MIN6 cells. MIN6 cells, clone 4,were maintained in Dulbecco's modifi ed Eagle's medium containing 25 mM glucose and 13% heat-inactivated FBS in a humidifi ed 5% CO 2 /95% O 2 incubator at 37 °C (Miyazaki et al. 1990; Yamato et al. 2013) . Incubation with HDACis was performed using 1 μM TSA, 10 mM VPA, and 10 mM NaB for 24 h unless stated otherwise.
Analysis of insulin release from MIN6 cells and insulin content. MIN6 cells were cultured with or without 1 μM TSA for 24 h. Aft er washing, MIN6 cells were preincubated with 3.3 mM glucose for 60 min, followed by culture with insulin secretagogues (3, 9, 15, 25 mM glucose, and 30 mM KCl) in HEPES-buff ered Krebs-Ringer solution for 60 min. Th e supernatant was collected and assayed for insulin concentration using an enzyme-linked immunosorbent assay (ELISA) kit (Mercodia, Uppsala, Sweden). MIN6 cells were lysed with RIPA buff er and the protein concentration of the cell lysate was measured using the Bradford method (Biorad, Hercules, CA). To measure insulin content, MIN6 cells were lysed with acid ethanol and extracted overnight at 4 °C, and the insulin concentration was measured by ELISA.
Immunocytochemistry. MIN6 cells were washed with phosphate-buff ered saline (PBS) and fi xed in 4% paraformaldehyde for 10 min. Aft er fi xation, the cells were rinsed with PBS, incubated for 5 min in 1% Triton X-100, and, aft er a second wash, incubated in blocking reagent (Blocking One, Nakalai Tesk, Kyoto, Japan). For both immunohistochemistry and immunocytochemistry, samples were incubated with a primary antibody for 60 min at room temperature (RT), washed with PBS, then incubated with a secondary antibody for 60 min at RT. Th e primary antibodies were anti-pdx1 (Transgenic, Kumamoto, Japan), diluted 1:100, and anti-mafa (Bethyl, Montgomery, TX), diluted 1:100. Th e secondary antibody was Alexa Fluor 488-conjugated anti-rabbit IgG (Molecular Probes, OR), diluted 1:500.
Quantitative RT-PCR. Total RNA was extracted from MIN6 cells using the acid guanidinium-phenol-chloroform method and cDNA was synthesized using ReverTra Ace (Toyobo, Tokyo, Japan). Quantitative RT-PCR analysis was carried out using SYBR Premix Ex Taq (Takara, Otsu, Japan). Th e reaction was performed with 1 μl cDNA per 25 μl reaction using a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA) under the following thermal cycling conditions: 95 °C for 10 s with no repeats, 95 °C for 5 s, and 60 °C for 31 s with 40 repeats. Th e relative quantity of the target transcripts was estimated by the standard curve method and the values were standardized using the relative expression values of Rpl32. Primer sequences are available upon request.
Detection of reactive oxygen species (ROS). Superoxide production was measured using a Total ROS/Superoxide Detection System (Enzo, Farmingdale, NY, USA) according to the manufacturer's instruction. For oxidative stress, MIN6 cells were preincubated with 1 μM TSA or control for 24 h, then incubated with 40 mM hydrogen peroxide (H 2 O 2 ) for 30 min. Superoxide content was measured as the relative intensity of the cells using NIH Image soft ware.
Statistical analysis. Results are presented as the mean ± SD. Statistical analyses were carried out by Student's t-test. A p-value <0.05 was considered statistically signifi cant.
Results
HDAC inhibitors and beta cell-specifi c transcription factors. Low concentrations of TSA, 0.01 and 0.1 μM, did not aff ect gene expression levels of Pdx1 or Mafa. However, 1 μM TSA suppressed expression of Pdx1 and Mafa, and Txnip expression was enhanced by 0.1 and 1 μM TSA (Figure 1 ). Th us, 1 μM TSA was used in this study otherwise stated. Other HDAC inhibitors, 10 mM VPA or 10 mM NaB, also inhibited gene expression of Pdx1 or Mafa but enhanced Txnip expression (Figure 2 ). MIN6 cells were cultured with or without 1 μM TSA for 24 h then stained using DAPI to count the number of nuclei. Th e protein expression of Pdx1 and Mafa were assessed by immunocytochemistry (Figure 3 ). Pdx1 and Mafa were detected in the nuclei of control MIN6 cells but this was reduced by TSA treatment. Th us, TSA treatment inhibited Pdx1 and Mafa expression at transcription and translation levels.
Insulin secretion and insulin content of MIN6 cells. Insulin secretion was assessed by static incubation of MIN6 cells. Basal insulin secretion, assessed by incubation with 3 and 9 mM glucose, was signifi cantly increased by TSA. However, glucose-induced insulin secretion using 15 and 25 mM glucose was signifi cantly suppressed (Figure 4) . TSA did not aff ect the insulin content of MIN6 cells (Figure 5) . Th ese results showed that TSA had a biphasic eff ect on insulin secretion. As insulin content was not aff ected by TSA, we concluded that TSA infl uenced the secretory machinery for insulin exocytosis but not production.
Hydrogen peroxide-induced ROS production. H 2 O 2 -induced ROS production was determined in response to TSA in MIN6 cells (Figure 6 ). ROS intensity in MIN6 cells was signifi cantly increased by TSA. Th erefore, TSA enhanced H 2 O 2 -induced ROS production suggesting that it increased the sensitivity to ROS-producing agents in pancreatic beta cells. 
Discussion
Our results showed that high doses of HDACis had a dual eff ect on insulin secretion in a pancreatic beta cell line, increasing basal insulin secretion but inhibiting glucose-induced insulin secretion. Gene expression of the transcription factors Pdx1 and Mafa was suppressed by HDACis, whereas Txnip gene expression was enhanced.
High doses of HDACis are known to be harmful to cells as induce cell cycle arrest and apoptosis (Zhang and Zhong 2014) . Th erefore, it is possible that suppression of several transcription factor genes, shown in our study, was a result of cell toxicity. However, as basal insulin secretion was enhanced by TSA, the effects of the HDACis were not solely due to a possible deterioration caused by a high dose.
We found that HDACis downregulated genes relevant to pancreatic function, Pdx1 and Mafa and upregulated expression of Txnip. Xu et al. (2013) have reported that Txnip inhibited Mafa gene expression through induction of mir-204. Th ey also reported that forced expression of Txnip did not infl uence the expression of Pdx1. Kubicek et al. (2012) have revealed that hydroxamic acid, a group of HDACis, inhibited gene expression of beta cell markers including Pdx1. Th ese data showed that HDACi-induced suppression of Pdx1 may be caused by a mechanism other than Txnip induction.
Several reports have shown that Txnip/TBP2, a negative regulator of thioredoxin (Schulze et al. 2004) , is increased by hyperglycemia and upregulated in the pancreas of diabetic animals (Minn et al. 2005) . Txnip exerts its proapoptotic eff ect at least in part by inhibiting thioredoxin and inducing oxidative stress. It is also well known that Txnip is strongly upregulated by high glucose concentrations. Th us, it is postulated that hyperglycemia di- rectly decreases thioredoxin activity by increasing Txnip resulting in an increased apoptotic signal in pancreatic beta cells. We also showed that forced expression of the thioredoxin gene in pancreatic beta cells using insulin promoter prevented destruction of pancreatic beta cells in both type 1 (Hotta et al. 1998 ) and type 2 diabetes models (Yamamoto et al. 2008) .
Txnip is also reported to be upregulated by HDACi by the CCAAT element and NF-YA of the Txnip promoter region (Butler et al. 2002) . Th ese results suggest that HDACis could directly induce the expression of Txnip. Indeed, TSA has been reported to induce Txnip gene expression in the INS-1 rat pancreatic beta cell line (Cha-Molstad et al. 2009 ). A recent report has also shown that another HDACi, CI994, increased Txnip gene expression through activation of histone acetyl transferase p300 in INS-1 cells (Bompada et al. 2016) . Another HDACi, SAHA, also increased Txnip levels, leading to increased ROS (Ungerstedt et al. 2012) . It has been also reported that overexpression of Txnip enhanced H 2 O 2 -induced oxidative stress (Junn et al. 2000) leading to deregulated insulin secretion from pancreatic beta cells. Indeed, our results also showed that H 2 O 2 -induced ROS production was enhanced by TSA treatment.
Our results showed that basal insulin secretion was enhanced by TSA. Certain levels of oxidative stress induced by glucose challenge have been shown to be a requisite for insulin secretion (Pi et al. 2007; Saadeh et al. 2012; Fu et al. 2013; Llanos et al. 2015) . We showed that ROS production was enhanced by TSA. Th erefore, the increased oxidative level of pancreatic beta cells induced by TSA may result in enhanced basal insulin secretion.
Our results showed that HDACis caused failure to suppress insulin secretion at low glucose concentrations and enhance insulin secretion at high glucose concentrations. In other words, when these HDACis are used clinically, high doses of HDACis may cause hypoglycemia in the fasting state and hyperglycemia in the fed state.
In conclusion, our results reveal that HDACis could modulate the insulin secretory capacity through oxidative stress. Th is modulation should be considered in the clinical use of HDACis.
